Cite
HARVARD Citation
Dirajlal-Fargo, S. et al. (2016). Changes in Insulin Resistance After Initiation of Raltegravir or Protease Inhibitors With Tenofovir-Emtricitabine: AIDS Clinical Trials Group A5260s. Open forum infectious diseases. p. . [Online].